search
mRNA vaccine
Trends
- 1Moderna starts Phase 1 trial of Ebola vaccine●Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the Zaire strain responsible for the outbreak in the Democratic Republic of the Congo. The trial marks the first human testing of the candidate, which uses the same mRNA technology behind Moderna's COVID-19 vaccine. Coverage is highlighting the company's growing pipeline and the urgent need for new Ebola countermeasures in central Africa.
- 2
Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.
- 3
Health outlets are highlighting an mRNA vaccine being developed for melanoma, the deadliest form of skin cancer. The approach uses the same mRNA technology proven in COVID-19 vaccines, training the immune system to recognize and attack tumor cells. WVU Medicine shared the update, and the item is drawing attention as trials of personalized cancer vaccines continue to advance globally.
- 4FAQ Released on Pharmacists' Understanding of mRNA Vaccine Technology▼FAQ: Pharmacist Understanding of mRNA Vaccine Technology
Drug Topics has published a FAQ addressing how well pharmacists understand mRNA vaccine technology. The piece answers common questions about the science behind mRNA vaccines and what pharmacists should know when advising patients. It reflects continued professional interest in keeping pharmacy staff up to date on vaccine technology and public communication.